COVID-19 Long Haulers and the Implications for Pharma 
Download the whitepaper
COVID-19 Long Haulers have emerged from the pandemic as a new population of COVID-19 patients that have shown post-recovery symptoms and co-morbidities that were nonexistent prior to infection. 

Download the whitepaper and discover:
  • Who Long Haulers are and their spectrum of indications
  • What challenges long haulers pose for HCPs, healthcare systems & patients
  • How a patient-centric care blueprint can support long haulers
Download the whitepaper to learn how pharma can improve patient outcomes for long haulers both during and after the pandemic.
Complete the form to download the whitepaper






By selecting this box, I consent to receiving marketing communications and information about IQVIA's offering by email.

Copyright © 2024 IQVIA Holdings Inc. and its affiliates. All rights reserved. Privacy Statement

DO NOT SELL MY PERSONAL INFORMATION